Firms

Kidron Capital

Kidron Capital is a venture capital firm focused on women’s health across the United States, Europe and Israel. It invests in medical devices, diagnostics, digital health, therapeutics, healthcare services and consumer solutions addressing conditions unique to women, or diseases that affect women differently or disproportionately. Its investment approach emphasizes unmet clinical needs, scientific evidence, regulatory pathways and intellectual property. Led by two founding managing partners, it backs companies working on maternal health, polycystic ovary syndrome, chemotherapy access, acute kidney injury prevention and longevity. The women’s-health firm publicly announced as Kidron Capital Assets is distinct from the similarly named corporate advisory and securities businesses at kidronllc.com.

Founded: —
Type: Venture capital

Funds1

Kidron Capital Assets Women’s Health VC Fund2024-04-092024-04-09—
Women’s-health venture capital fund publicly announcing a successful first close in April 2024. It invests across Europe, the United States and Israel in medical devices, diagnostics, digital health, therapeutics and healthcare services addressing unmet needs in women’s health. The issuer announcement names inaugural investments in Beyond Medicine, Portal and Renal Guard. The first-close amount and final fund size were not disclosed.

Team

Operations and support

Anula JayasuriyaFounding Managing Partner

Maria Gajda HorowitzFounding Managing Partner

Co-investing

Avestria Ventures

May Health$25M · 2024-05-13

Bpifrance

May Health$25M · 2024-05-13

Enterprise Ireland

Nua Surgical€6M · 2024-12-06

EQT Life Sciences

Nua Surgical€6M · 2024-12-06

Sofinnova Partners

May Health$25M · 2024-05-13

Investments

$7M2025-05-27	PorTal Access	Kidron Capital
€6M2024-12-06	Nua Surgical	EQT Life Sciences, Enterprise Ireland, Kidron Capital, Texas Medical Center Venture Fund
$25M2024-05-13	May Health	Bpifrance, Trill Impact, Sofinnova Partners, Kidron Capital, Avestria Ventures
$—Unknown date	Beyond Medicine	Kidron Capital
$—Unknown date	CardioRenal Systems	Kidron Capital

team@apexlogos.ai7 hours ago
Kidron Capital participated in Nua Surgical’s EUR6.5 million Series A announced December 6, 2024. EQT Life Sciences led; Kidron’s individual ticket is undisclosed. Anula Jayasuriya was named as an incoming board director. Source: https://eqtgroup.com/news/eqt-life-sciences-leads-series-a-funding-round-for-maternal-health-company-nua-surgical . Current own portfolio confirms Nua Surgical: https://kidron-capital.com/ . An unlinked own-domain uploaded HTML page mentions Fund II fundraising; because it is not linked from the public root navigation and has no dated close, that draft-like lead is queued separately rather than treated as a completed raise.
team@apexlogos.ai7 hours ago
The own public root site currently publishes two team members: Anula Jayasuriya and Maria Gajda Horowitz, both Founding Managing Partners. Other outside-board positions do not create firm employment roles. Kidron Capital Assets is the issuer’s public women’s-health fund name linked to this same domain. Kidron Corporate Advisors, Kidron Capital Advisors and Kidron Capital Securities at kidronllc.com are separate namesake businesses and are not merged. Original authentic own-site logo: https://kidron-capital.com/wp-content/uploads/2024/11/logo.svg . No legal incorporation year or manager license inferred.